Literature DB >> 18072587

Optimization of HIV-1 infectivity assays.

Jennifer Jones1, William Whitford, Frederic Wagner, Olaf Kutsch.   

Abstract

HIV-1 reporter cell lines are the backbone of diagnostic assays, vaccine and drug development efforts. Performing HIV-1 infection experiments in a T cell background is desirable for many reasons. However, a low susceptibility to infection with primary patient isolates in available reporter T cell lines has limited such efforts. We here demonstrate that optimization of HIV-1 receptor expression and the utilization of serum free medium compositions can increase susceptibility of reporter T cell lines to HIV-1 infection by up to two orders of magnitude.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18072587     DOI: 10.2144/000112624

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  13 in total

1.  Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.

Authors:  Frank Wolschendorf; Alexandra Duverger; Jennifer Jones; Frederic H Wagner; Jason Huff; William H Benjamin; Michael S Saag; Michael Niederweis; Olaf Kutsch
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.

Authors:  Tara G Edmonds; Haitao Ding; Xing Yuan; Qing Wei; Kendra S Smith; Joan A Conway; Lindsay Wieczorek; Bruce Brown; Victoria Polonis; John T West; David C Montefiori; John C Kappes; Christina Ochsenbauer
Journal:  Virology       Date:  2010-09-21       Impact factor: 3.616

4.  RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.

Authors:  Katarzyna Kaczmarek Michaels; Frank Wolschendorf; Gillian M Schiralli Lester; Malini Natarajan; Olaf Kutsch; Andrew J Henderson
Journal:  Virology       Date:  2015-09-14       Impact factor: 3.616

5.  An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.

Authors:  Alexandra Duverger; Frank Wolschendorf; Mingce Zhang; Fredric Wagner; Brandon Hatcher; Jennifer Jones; Randall Q Cron; Renee M van der Sluis; Rienk E Jeeninga; Ben Berkhout; Olaf Kutsch
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

6.  Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.

Authors:  Takao Shishido; Frank Wolschendorf; Alexandra Duverger; Frederic Wagner; John Kappes; Jennifer Jones; Olaf Kutsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

7.  Determinants of the establishment of human immunodeficiency virus type 1 latency.

Authors:  Alexandra Duverger; Jennifer Jones; Jori May; Frederic Bibollet-Ruche; Frederic A Wagner; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

8.  Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.

Authors:  Morgane Bomsel; Yonatan Ganor
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.

Authors:  Aiping Wang; Fang Chen; Yingjie Wang; Mingqiang Shen; Yang Xu; Jian Hu; Song Wang; Fang Geng; Cheng Wang; Xinze Ran; Yongping Su; Tianmin Cheng; Junping Wang
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

10.  Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells.

Authors:  Daniel O Ochiel; Christina Ochsenbauer; John C Kappes; Mimi Ghosh; John V Fahey; Charles R Wira
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.